Archived Insight | July 20, 2022

Roe Overturned: What Employers & Plan Sponsors Need to Know

In the most consequential reproductive rights case in generations, the U.S. Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organization has overturned Roe v. Wade. This decision impacts employers and plan sponsors, which now have a number of actions to consider.

Roe Overturned: What Employers & Plan Sponsors Need to Know (1)

On July 20, our national compliance and clinical experts discussed the top employer and plan sponsor concerns including:

  • The decision, impact on multi-state entities and potential ERISA preemption
  • Required changes and strategic decisions impacting health plans, travel benefits, paid leave, fertility coverage and health reimbursement arrangements
  • Pharmaceutical benefits related to pregnancy, such as contraceptives and medication abortion and coordination with pharmacy benefit managers
  • Financial security, dependent and education benefits, communication issues and potential disparate impact on workforce diversity

Watch the Webinar

 

Get the Slides

Don’t have time to watch a video right now? No worries. Here is a copy of the slides.

Download Now

See more insights

Black Female Pharmacist Observes Medicines On Shelves In A Pharmacy

PBM Transparency, Fiduciary Risk & Emerging Compliance Issues: A 2026 Update for Plan Sponsors

A practical webinar for plan sponsors on PBM transparency, fiduciary risk and emerging compliance issues affecting pharmacy benefits.
Two Businesspeople Working Together On A Laptop In The Office

Why Oversight of Vendors’ AI Use Is a Governance Essential

When vendors add AI features, risk profiles can shift quietly. Learn how structured oversight makes vendor AI use visible and governable.
Business People Having A Meeting In Office Boardroom

Evaluating the Impact and Outcomes of Point Solutions

Learn how plan sponsors can evaluate healthcare point solutions by measuring ROI, costs and outcomes using data and clinical evidence.

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.

Don't miss out. Join 16,000 others who already get the latest insights from Segal.